REGENXBIO Inc. — Investor Relations & Filings
REGENXBIO Inc. is a clinical-stage company focused on the development and commercialization of gene therapies. The company's mission is to improve lives by delivering one-time treatments for a broad range of common and rare diseases. Central to its approach is the proprietary NAV® Technology Platform, an extensive portfolio of adeno-associated virus (AAV) vectors designed for targeted gene delivery. REGENXBIO's therapeutic pipeline includes product candidates for diseases in the retinal, metabolic, and neurodegenerative areas. The company operates with integrated, in-house manufacturing capabilities to support its clinical programs from development through to potential commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| DEF 14A - REGENXBIO Inc. (0001590877) (Filer) | 2026-04-14 | English | |
| 8-K - REGENXBIO Inc. (0001590877) (Filer) | 2026-03-20 | English | |
| 8-K - REGENXBIO INC. (0001590877) (Filer) | 2026-02-10 | English | |
| 4 Filing | 2026-02-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45974653 | 10-Q | 2026-05-14 | English | ||
| 45969083 | 8-K | 2026-05-14 | English | ||
| 34525941 | DEF 14A - REGENXBIO Inc. (0001590877) (Filer) | 2026-04-14 | English | ||
| 33002728 | 8-K - REGENXBIO Inc. (0001590877) (Filer) | 2026-03-20 | English | ||
| 32894623 | 8-K - REGENXBIO INC. (0001590877) (Filer) | 2026-02-10 | English | ||
| 30770565 | 4 Filing | 2026-02-03 | English | ||
| 30770507 | 4 Filing | 2026-02-03 | English | ||
| 30770413 | 4 Filing | 2026-01-29 | English | ||
| 30770258 | 8-K Filing | 2026-01-28 | English | ||
| 30770335 | SCHEDULE 13G/A Filing | 2026-01-21 | English | ||
| 12722896 | PRIMARY DOCUMENT | 2026-01-08 | English | ||
| 12722894 | PRIMARY DOCUMENT | 2026-01-08 | English | ||
| 12722903 | PRIMARY DOCUMENT | 2026-01-08 | English | ||
| 12722893 | PRIMARY DOCUMENT | 2026-01-08 | English | ||
| 12722895 | PRIMARY DOCUMENT | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
REGENXBIO Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32827/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32827 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32827 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32827 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32827}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for REGENXBIO Inc. (id: 32827)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.